ESMO Gastrointestinal Oncology Gastroenterology
Dual versus single-agent immune checkpoint inhibitor therapy in microsatellite instability-high metastatic colorectal cancer: an analysis based on reconstructed patient data
The publisher did not provide an abstract — full text is available via the link below.